Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
WuXi AppTec Co., Ltd. Class H ( (HK:2359) ) has shared an announcement.
WuXi AppTec Co., Ltd. has revised the terms of reference for its Nomination Committee to enhance the governance and appointment processes for directors and senior management. This move aims to optimize board composition and strengthen corporate governance, reflecting the company’s commitment to maintaining high standards in its leadership structure.
The most recent analyst rating on (HK:2359) stock is a Buy with a HK$133.00 price target. To see the full list of analyst forecasts on WuXi AppTec Co., Ltd. Class H stock, see the HK:2359 Stock Forecast page.
More about WuXi AppTec Co., Ltd. Class H
WuXi AppTec Co., Ltd. operates in the pharmaceutical and biotechnology industry, providing comprehensive laboratory and manufacturing services. The company focuses on enabling global healthcare organizations to advance their drug development processes.
Average Trading Volume: 9,084,704
Technical Sentiment Signal: Buy
Current Market Cap: HK$323.9B
See more insights into 2359 stock on TipRanks’ Stock Analysis page.